Interface gets ISO 13485:2003 certification

Closely held Interface Biologics has received ISO 13485:2003 certification, a quality management system that emphasizes design, process, quality and manufacturing reliability for medical device products. “Achieving certification to ISO 13485:2003 illustrates Interface’s commitment to quality for our customers, partners, and for the patients and healthcare providers who will rely on medical devices that incorporate our [...]

Interface Biologics CSO wins Julia Levy Award

Dr. Paul Santerre, a co-founder and CSO of closely held Interface Biologics, will receive the Julia Levy Award from the Canadian section of the Society of Chemical Industry on March 25. The Julia Levy award recognizes successful commercialization of innovation in Canada in the field of bio-medical science and engineering, with a particular focus on [...]